Ledger.Open graph →
SEC Form D · filed March 4, 2015

KEMPHARM, INC

Offering
$4.0M
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CORALVILLE, IA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Gordon K. Johnson · Coralville, IAExecDavid S. Tierney · Coralville, IADirectorMatthew R. Plooster · Coralville, IADirectorTravis C. Mickle · Coralville, IAExec · Director · PromoterRichard W. Pascoe · Coralville, IADirectorJoseph B. Saluri · Coralville, IADirectorSven Guenther · Coralville, IAExec · DirectorTracy M. Woody · Coralville, IAExecChristal M. Mickle · Coralville, IAExec · DirectorDanny L. Thompson · Coralville, IADirectorJonathan S. Leff · Seattle, WADirectorGordon K. Johnson · Coralville, IAExecDavid S. Tierney · Shrewsbury, NJDirectorMatthew R. Plooster · Coralville, IADirectorTravis C. Mickle · Coralville, IAExec · Director · PromoterTracy M. Woody · Coralville, IAExecRichard W. Pascoe · Solana Beach, CADirectorChristal M. Mickle · Coralville, IAExec · DirectorDanny L. Thompson · Coralville, IADirectorJoseph B. Saluri · Coralville, IADirectorSven Guenther · North Liberty, IAExec · DirectorJonathan S. Leff · Coralville, IADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗